Handelsbanken Fonder’s AstraZeneca AZN Stock Holding History

Handelsbanken Fonder’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,962	Closed	-$266K	–	1528
2024 Q1	$266K	Sell	1,962 -8,153	-81%	-$1.08M	﹤0.01%	1427
2023 Q4	$1.36M	Hold	10,115	–	–	0.01%	679
2023 Q3	$1.37M	Hold	10,115	–	–	0.01%	635
2023 Q2	$1.45M	Hold	10,115	–	–	0.01%	617
2023 Q1	$1.4M	Hold	10,115	–	–	0.01%	602
2022 Q4	$1.37M	Hold	10,115	–	–	0.01%	583
2022 Q3	$1.11M	Hold	10,115	–	–	0.01%	628
2022 Q2	$1.34M	Sell	10,115 -600	-6%	-$78.7K	0.01%	607
2022 Q1	$1.42M	Sell	10,715 -11,150	-51%	-$1.34M	0.01%	670
2021 Q4	$2.55M	Sell	21,865 -4,800	-18%	-$565K	0.01%	568
2021 Q3	$3.2M	Buy	+26,665	New	+$3.1M	0.02%	547

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Handelsbanken Fonder's AZN Position: Q2 2024 in Review

Handelsbanken Fonder sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 1,962 shares — an estimated $266K sold.

Handelsbanken Fonder first reported a position in AZN in Q3 2021 and held it in 11 quarters. The position peaked at $3.2M in Q3 2021. 1,212 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

Handelsbanken Fonder reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
Handelsbanken Fonder sold 1,962 AstraZeneca shares in Q2 2024, an estimated $266K.
Handelsbanken Fonder first reported a position in AstraZeneca in Q3 2021 and held it in 11 quarters.
Handelsbanken Fonder's AstraZeneca position peaked at $3.2M in Q3 2021.
1,212 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.